Rentokil Initial Investor Day Presentation Deck

The Transformation Continues a B Rentokil Initial Total Growth Organic Revenue M&A Spend Net Operating Margin APBTA Profit Growth Free Cash Flow conversion Progressive Dividends Net debt to EBITDA S&P Rating Pension 2013 4.5% £10m 8.8% 44% £38.6m 2.5x BBB- In deficit 2017 20.6% £281m 13.2% 13.8% 87% £64.3m c.1.9x BBB Fully Funded Current Targets 5% - 8% 3 - 4% FY £450m - £500m in 2021 c.10% 90% BBB Buy Out 2022+ 6% -9% 4% - 5% Annual Guidance 10%+ 90% BBB Complete 143

View entire presentation